CHAMPIONS ONCOLOGY, INC. Cash Flow Statement
CSBR|14 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 14 fiscal years. All figures from audited SEC 10-K filings.
CHAMPIONS ONCOLOGY, INC. used $6M in operating cash flow and negative free cash flow of $7M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.3M | $4.7M | $548.0K | $362.0K | -$2.1M | $362.0K | -$2.1M | -$6.9M | -$10.4M | -$13.1M | -$7.4M | -$6.3M | -$8.7M | -$6.3M |
| Depreciation & Amortization | $1.9M | $1.6M | $1.5M | $925.0K | $825.0K | $925.0K | $825.0K | $168.0K | $156.0K | $214.0K | $213.0K | $203.0K | $105.0K | $203.0K |
| Operating Cash Flow | -$6.1M | $7.4M | $6.5M | -$1.7M | $2.9M | -$1.7M | $2.9M | -$2.8M | -$6.4M | -$9.6M | -$3.4M | -$4.3M | -$5.2M | -$4.3M |
| Capital Expenditures | $836.0K | $389.0K | $2.4M | $3.3M | $2.2M | $3.3M | $2.2M | $766.0K | $322.0K | $119.0K | $234.0K | $57.0K | $519.0K | $57.0K |
| Free Cash Flow | -$7.0M | $7.0M | $4.1M | -$5.0M | $685.0K | -$5.0M | $685.0K | -$3.6M | -$6.7M | -$9.7M | -$3.7M | -$4.4M | -$5.7M | -$4.3M |
| Share Buybacks | $634.0K | $0 | $0 | - | - | - | - | - | - | - | - | - | - | - |
| FCF Margin | -13.9% | 12.3% | 8.4% | -12.1% | 2.1% | -12.1% | 2.1% | -23.4% | -60.2% | -110.0% | -31.8% | -52.4% | -80.4% | -52.3% |